MARILYN JUSTICE: Open Payments
NPI 1700459286 · LENOIR CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 41 payments from 18 companies in 2025. Trend: 2023 $228 · 2024 $475 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Lilly USA, LLC | 6 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Esperion Therapeutics, Inc. | 3 | $44 |
| PFIZER INC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Corcept Therapeutics | 2 | $29 |
Products named: FARXIGA, CAPLYTA, JARDIANCE, Kerendia, NEXLETOL, XIFAXAN, REXULTI, BREZTRI.
Industry payments across TN — which companies pay providers there.
